About NeuraMedica
NeuraMedica is a Healthcare company based in Oregon City (United States) founded in 2014 by Neil Roundy and Rachel Dreilinger. Bioabsorbable dural clips are developed for durotomy and spinal closures. It operates on a Direct-to-Consumer (D2C) model. NeuraMedica has raised $1.85 million across 6 funding rounds from investors including NIH and HHS. Its chief executive, as recorded, is Rachel Dreilinger. NeuraMedica offers products and services including DuraFuse Dural Clips. Its focus areas include Medical Devices and Neurosurgical Devices. Its legal entity is NeuraMedica Inc. Its competitors include Stryker, NuVasive and CARLSMED; 2 of its 3 listed competitors have raised funding.
Company details
NeuraMedica is engaged in the development of innovative medical devices for neurosurgery. The company specializes in solutions for spinal dura closure, offering products like DuraFuse Dural Clips. These clips are designed to provide rapid, simple, and secure closure during spinal procedures, reducing operation time and preventing cerebrospinal fluid leakage. The focus is placed on bioabsorbable and imaging-compatible technologies to enhance surgical outcomes in the healthcare sector.
- Headquarters Oregon City, United States
- Founders Neil Roundy, Rachel Dreilinger
- SectorsHealthcare
- Phone•••• ••••
- Website neuramedica.com
- Legal Name Neuramedica Inc.
- Total Equity Funding$1.85M (USD)
in 6 rounds
- Latest Funding Round$709.62K (USD), Seed
Jun 2023
- InvestorsNIH
& 1 more
Products & Services of NeuraMedica
NeuraMedica offers a comprehensive portfolio of products and services, including DuraFuse Dural Clips.
Bioabsorbable clips for rapid spinal dura closure.
Funding Insights of NeuraMedica
NeuraMedica has successfully raised a total of $1.85M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $709.62 thousand completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.85M
- Total Rounds 6
- Last Round Seed — $709,622
- First Round $225,000
(Dec 2016)
- Investors Count 2
All 6 funding rounds of NeuraMedica with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in NeuraMedica
NeuraMedica has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for NeuraMedica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NeuraMedica
5 people are tracked at NeuraMedica (2 in leadership, 2 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Neil Roundy | Co-Founder | Leadership |
Rachel Dreilinger | Co-Founder & CEO | Leadership |
Michael Tippie | Advisor | Board & advisors |
Coni Rosati | Advisor | Board & advisors |
Bryon Morse | Senior Mechanical Engineer | Team |
Complete people profiles for NeuraMedica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NeuraMedica
3 dated milestones of NeuraMedica across 9 years, from founding to its latest funding, stage changes and deals.
- Founded NeuraMedica is founded.
- Funding First funding round of $225K.
- Funding Latest funding round, Seed, of $710K.
Competitors of NeuraMedica
NeuraMedica has 3 listed competitors in our database, 2 of them funded. They include Stryker, NuVasive and CARLSMED.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| stryker.com | 1941 | Kalamazoo, United States | 25,035 | 3D-printed orthopedic products are manufactured for medical applications. | ||
| nuvasive.com | 1997 | San Diego, United States | $54.1M | 2,450 | Smart surgical devices for spinal surgery are developed. | |
| carlsmed.com | 2018 | San Diego, United States | $109.63M | 59 | Developer of devices for spine surgery |
Detailed competitors of NeuraMedica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as NeuraMedica (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NeuraMedica
NeuraMedica was founded in 2014 and raised its 1st funding round 2 years after it was founded.
NeuraMedica is headquartered in Oregon City, United States. It is registered at Oregon City, Oregon, United States.
Rachel Dreilinger is the CEO of NeuraMedica, as recorded in our data. They have also founded this company.
NeuraMedica is a funded company, having raised a total of $1.85M across 6 funding rounds to date. The company's 1st funding round was a Grant of $225K, raised on Dec 2016.
NeuraMedica is engaged in the development of innovative medical devices for neurosurgery. The company specializes in solutions for spinal dura closure, offering products like DuraFuse Dural Clips. These clips are designed to provide rapid, simple, and secure closure during spinal procedures, reducing operation time and preventing cerebrospinal fluid leakage. The focus is placed on bioabsorbable and imaging-compatible technologies to enhance surgical outcomes in the healthcare sector.
NeuraMedica offers DuraFuse Dural Clips.
NeuraMedica operates through Neuramedica Inc..